Arzneimittelinduzierte Leberschäden

Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46: 1323–1330
Article PubMed CAS Google Scholar
Sgro C, Clinard F, Ouazir K et al (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36: 451–455
Article PubMed Google Scholar
Markova SM et al (2013) Association of CYP2C9*2 with Bosentan-Induced Liver Injury. Clin Pharmacol Ther, doi:10.1038/clpt.2013.143 (Epub ahead of print)

Interessenkonflikt. S. Brost und M. Müller-Schilling geben an, dass kein Interessenkonflikt besteht.

Author information

Klinik und Poliklinik für Innere Medizin I, Gastroenterologie, Endokrinologie, Rheumatologie und Infektiologie, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland
S. Brost & M. Müller-Schilling

Authors

S. Brost
View author publications
You can also search for this author in PubMed Google Scholar
M. Müller-Schilling
View author publications
You can also search for this author in PubMed Google Scholar

Correspondence to S. Brost.

Brost, S., Müller-Schilling, M. Arzneimittelinduzierte Leberschäden. Gastroenterologe 8, 448–450 (2013). https://doi.org/10.1007/s11377-013-0808-9

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.